Dapagliflozin Cuts CV Risk in Heart Failure With Preserved LVEF
Risk reduced for primary outcome of worsening heart failure or cardiovascular death
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Risk reduced for primary outcome of worsening heart failure or cardiovascular death
Only registered members have full access to PracticeUpdate content.